Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06216301
Title LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC (LUNAR-2)
Acronym LUNAR-2
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors NovoCure GmbH
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
BRCR Global RECRUITING Plantation Florida 33324 United States Details
Cancer Treatment Centers of America (CTCA) RECRUITING Zion Illinois 60099 United States Details
Franciscan Health Indianapolis RECRUITING Indianapolis Indiana 46237 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field